The small heat shock proteins and their role in human disease

FEBS Journal

Volumn 272, Issue 11, 2005, Pages 2613-2627

  Sun, Yu ^a   MacRae, Thomas H ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Disease; Molecular chaperone; Small heat shock protein; Stress resistance; Therapeutic intervention

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; ADENOVIRUS VECTOR; ADVANCED GLYCATION END PRODUCT; ALPHA CRYSTALLIN; ARIMOCLOMOL; BETA CRYSTALLIN; CHAPERONE; CISPLATIN; DESMIN; DOXORUBICIN; GAMMA CRYSTALLIN; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 20; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; HEAT SHOCK TRANSCRIPTION FACTOR 1; HYDROXYLAMINE; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PANTETHINE; RADICICOL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CATARACT; CONGESTIVE HEART FAILURE; GENE MUTATION; GENE THERAPY; HEART INFARCTION; HUMAN; HUNTINGTON CHOREA; LYMPHOMA CELL; MELANOMA CELL; MOTOR NEUROPATHY; MOUTH CARCINOMA; MULTIPLE SCLEROSIS; MYOPATHY; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN DOMAIN; REPERFUSION INJURY; REVIEW; SARCOMA CELL; STROKE; TUMOR GROWTH;

ANIMALS; CATARACT; CRYSTALLINS; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; NEOPLASMS; NERVOUS SYSTEM DISEASES;

MAMMALIA;

EID: 20444478694     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04708.x     Document Type: Review

References (164)

1. MacRae TH (2000) Structure and function of small heat shock/α-crystallin proteins: established concepts and emerging ideas. Cell Mol Life Sci 57, 899-913.
2. Frank E, Madsen O, van Rheede T, Ricard G, Huynen MA & de Jong WW (2004) Evolutionary diversity of vertebrate small heat shock proteins. J Mol Evol 59, 792-805.
3. Augusteyn RC (2004) α-Crystallin: a review of its structure and function. Clin Exp Optom 87, 356-366.
4. Laksanalamai P & Robb FT (2004) Small heat shock proteins from extremophiles: a review. Extremophiles 8, 1-11.
5. Horwitz J (2003) Alpha-crystallin. Exp Eye Res 76, 145-153.
6. Narberhaus F (2002) α-Crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network. Microbiol Mol Biol Rev 66, 64-93.
7. Sun W, Van Montagu M & Verbruggen N (2002) Small heat shock proteins and stress tolerance in plants. Biochim Biophys Acta 1577, 1-9.
8. Scharf K-D, Siddique M & Vierling E (2001) The expanding family of Arabidopsis thaliana small heat stress proteins and a new family of proteins containing α-crystallin domains (Acd proteins). Cell Stress Chaperones 6, 225-237.
9. Kappe G, Aquilina JA, Wunderink L, Kamps B, Robinson CV, Garate T, Boelens WC & de Jong WW (2004) Tsp36, a tapeworm small heat-shock protein with a duplicated α-crystallin domain, forms dimers and tetramers with good chaperone-like activity. Proteins Struct Funct Bioinform 57, 109-117.
10. Bera S & Abraham EC (2002) The αA-crystallin R116C mutant has a higher affinity for forming heteroaggregates with αB-crystallin. Biochemistry 41, 297-305.
11. Andley UP, Patel HC & Xi J-H (2002) The R116C mutation in αA-crystallin diminishes its protective ability against stress-induced lens epithelial cell apoptosis. J Biol Chem 277, 10178-10186.
12. Shroff NP, Cherian-Shaw M, Bera S & Abraham EC (2000) Mutation of R116C results in highly oligomerized αA-crystallin with modified structure and defective chaperone-like function. Biochemistry 39, 1420-1426.
13. Cobb BA & Petrash JM (2000) Structural and functional changes in the αA-crystallin R116C mutant in hereditary cataracts. Biochemistry 39, 15791-15798.
14. Kumar LVS, Ramakrishna T & Rao ChM (1999) Structural and functional consequences of the mutation of a conserved arginine residue in αA and αB crystallins. J Biol Chem 274, 24137-24141.
15. Bova MP, Yaron O, Huang Q, Ding L, Haley DA, Stewart PL & Horwitz J (1999) Mutation R120G in αB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc Natl Acad Sci USA 96, 6137-6142.
16. Perng MD, Muchowski PJ, van den IJssel P, Wu GJS, Hutcheson AM, Clark JI & Quinlan RA (1999) The cardiomyopathy and lens cataract mutation in αB-crystallin alters its protein structure, chaperone activity, and interaction with intermediate filaments in vitro. J Biol Chem 274, 33235-33243.
17. Fu X & Chang Z (2004) Temperature-dependent subunit exchange and chaperone-like activities of Hsp16.3, a small heat shock protein from Mycobacterium tuberculosis. Biochem Biophys Res Commun 316, 291-299.
18. Sobott F, Benesch JLP, Vierling E & Robinson CV (2002) Subunit exchange of multimeric protein complexes: real-time monitoring of subunit exchange between small heat shock proteins by using electrospray mass spectrometry. J Biol Chem 277, 38921-38929.
19. Gu L, Abulimiti A, Li W & Chang Z (2002) Monodisperse HSP16.3 nonamer exhibits dynamic dissociation and reassociation, with the nonamer dissociation prerequisite for chaperone-like activity. J Mol Biol 319, 517-526.
20. Bova MP, Huang Q, Ding L & Horwitz J (2002) Subunit exchange, conformational stability, and chaperone-like function of the small heat shock protein 16.5 from Methanococcus jannaschii. J Biol Chem 277, 38468-38475.
21. Golenhofen N, Perng MD, Quinlan RA & Drenckhahn D (2004) Comparison of the small heat shock proteins αB-crystallin, MKBP, HSP25, HSP20 and cvHSP in heart and skeletal muscle. Histochem Cell Biol 122, 415-425.
22. Kappé G, Franck E, Verschuure P, Boelens WC, Leunissen JAM & de Jong WW (2003) The human genome encodes 10 α-crystallin-related small heat shock proteins: HspB1-10. Cell Stress Chaperones 8, 53-61.
23. Taylor RP & Benjamin IV (2005) Small heat shock proteins: a new classification scheme in mammals. J Mol Cell Cardiol 38, 433-444.
24. Bloemendal H, de Jong W, Jaenicke R, Lubsen NH, Slingsby C & Tardieu A (2004) Ageing and vision: structure, stability and function of lens crystalline. Prog Biophys Mol Biol 86, 407-485.
25. Horwitz J (2000) The function of alpha-crystallin in vision. Sem Cell Dev Biol 11, 53-60.
26. Clark JI & Muchowski PJ (2000) Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol 10, 52-59.
27. Clark JI, Matsushima H, David LL & Clark JM (1999) Lens cytoskeleton and transparency: a model. Eye 13, 417-424.
28. McAvoy JW, Chamberlain CG, de Iongh RU, Hales AM & Lovicu FJ (1999) Lens development. Eye 13, 425-437.
29. Cobb BA & Petrash JM (2000) Characterization of α-crystallin- plasma membrane binding. J Biol Chem 275, 6664-6672.
30. Weinreb O, Dovrat A, Dunia I, Benedetti EL & Bloemendal H (2001) UV-A-related alterations of young and adult lens water-insoluble α-crystallin, plasma membranous and cytoskeletal proteins. Eur J Biochem 268, 536-543.
31. Quinlan RA, Sandilands A, Procter JE, Prescott AR, Hutcheson AM, Dahm R, Gribbon C, Wallace P & Carter JM (1999) The eye lens cytoskeleton. Eye 13, 409-416.
32. Meehan S, Berry Y, Luisi B, Dobson CM, Carver JA & MacPhee CE (2004) Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J Biol Chem 279, 3413-3419.
33. Kamei A, Takamura S, Nagai M & Takeuchi N (2004) Phosphoproteome analysis of hereditary cataractous rat lens α-crystallin. Biol Pharm Bull 27, 1923-1931.
34. Kamei A, Iwase H & Masuda K (1997) Cleavage of amino acid residue(s) from the N-terminal region of αA- and αB-crystallins in human crystalline lens during aging. Biochem Biophys Res Commun 231, 373-378.
35. Takeuchi N, Ouchida A & Kamei A (2004) C-terminal truncation of α-crystallin in hereditary cataractous rat lens. Biol Pharm Bull 27, 308-314.
36. Srivastava OP & Srivastava K (2003) Existence of deamidated αB-crystallin fragments in normal and cataractous human lenses. Mol Vis 9, 110-118.
37. Takemoto LJ (1997) Changes in the C-terminal region of alpha-Aα crystallin during human cataractogenesis. Int J Biochem Cell Biol 29, 311-315.
38. Gupta R & Srivastava OP (2004) Effect of deamidation of asparagine 146 on functional and structural properties of human lens αB-crystallin. Invest Ophthalmol Vis Sci 45, 206-214.
39. Gupta R & Srivastava OP (2004) Deamidation affects structural and functional properties of human αA-crystallin and its oligomerization with αB-crystallin. J Biol Chem 279, 44258-44269.
40. Takemoto L & Boyle D (1998) The possible role of α-crystallins in human senile cataractogenesis. Int J Biol Macromol 22, 331-337.
41. Takemoto L & Boyle D (1998) Deamidation of specific glutamine residues from alpha-A crystallin during aging of the human lens. Biochemistry 37, 13681-13685.
42. Takemoto L & Boyle D (1998) Determination of the in vivo deamidation rate of asparagine-101 from alpha-A crystallin using microdissected sections of the aging human lens. Exp Eye Res 67, 119-120.
43. Fujii N, Uchida H & Saito T (2004) The damaging effect of UV-C irradiation on lens a-crystallin. Mol Vis 10, 814-820.
44. Chen S-J, Sun T-X, Akhtar NJ & Liang JJ-N (2001) Oxidation of human lens recombinant αA-crystallin and cysteine-deficient mutants. J Mol Biol 305, 969-976.
45. Cherian-Shaw M, Smith JB, Jiang X-Y & Abraham EC (1999) Intrapolypeptide disulfides in human αA-crystallin and their effect on chaperone-like function. Mol Cell Biochem 199, 163-167.
46. Cherian M & Abraham EC (1995) Decreased molecular chaperone property of α-crystallins due to posttranslational modifications. Biochem Biophys Res Commun 208, 675-679.
47. Seidler NW, Yeargans GS & Morgan TG (2004) Carnosine disaggregates glycated α-crystallin: an in vitro study. Arch Biochem Biophys 427, 110-115.
48. Kumar MS, Reddy PY, Kumar PA, Surolia I & Reddy GB (2004) Effect of dicarbonyl-induced browning on α-crystallin chaperone-like activity: physiological significance and caveates of in vitro aggregation assays. Biochem J 379, 273-282.
49. Kumar MS, Mrudula T, Mitra N & Reddy GB (2004) Enhanced degradation and decreased stability of eye lens α-crystallin upon methylglyoxal modification. Exp Eye Res 79, 577-583.
50. Nagaraj RM, Oya-Ito T, Padayatti PS, Kumar R, Mehta S, West K, Levison B, Sun J, Crabb JW & Padival AK (2003) Enhancement of chaperone function of α-crystallin by methylglyoxal modification. Biochemistry 42, 10746-10755.
51. Derham BK & Harding JJ (2002) Effects of modifications of α-crystallin on its chaperone and other properties. Biochem J 364, 711-717.
52. Thampi P, Zarina S & Abraham EC (2002) α-Crystallin chaperone function in diabetic rat and human lenes. Mol Cell Biochem 229, 113-118.
53. Blakytny R, Carver JA, Harding JJ, Kilby GW & Sheil MM (1997) A spectroscopic study of glycated bovine α-crystallin: investigation of flexibility of the C-terminal extension, chaperone activity and evidence for diglycation. Biochim Biophys Acta 1343, 299-315.
54. Fujii N, Awakura M, Takemoto L, Inomata M, Takata T, Fujii N & Saito T (2003) Characterization of αA-crystallin from high molecular weight aggregates in the normal human lens. Mol Vis 9, 315-322.
55. Fujii N, Matsumoto S, Hiroki K & Takemoto L (2001) Inversion and isomerization of Asp-58 residue in human αA-crystallin from normal aged and cataractous lenses. Biochim Biophys Acta 1549, 179-187.
56. Shridas P, Sharma Y & Balasubramanian D (2001) Transglutaminase- mediated cross-linking of α-crystallin: structural and functional consequences. FEBS Lett 499, 245-250.
57. Westermann S & Weber K (2003) Post-translational modifications regulate microtubule function. Nat Rev Mol Cell Biol 4, 938-947.
58. MacRae TH (1997) Tubulin post-translational modifications. Enzymes and their mechanisms of action. Eur J Biochem 244, 265-278.
59. Cherian M, Smith JB, Jiang X-Y & Abraham EC (1997) Influence of protein-glutathione mixed disulfide on the chaperone-like function of α-crystallin. J Biol Chem 272, 29099-29103.
60. Litt M, Kramer P, LaMorticella DM, Murphey W, Lovrien EW & Weleber RG (1998) Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene. CRYAA Hum Mol Genet 7, 471-474.
61. Mackay DS, Andley UP & Shiels A (2003) Cell death triggered by a novel mutation in the alphaA-crystallin gene underlies autosomal dominant cataract linked to chromosome 21q. Eur J Hum Genet 11, 784-793.
62. Zobel ATC, Loranger A, Marceau N, Thériault JR, Lambert H & Landry. J (2003) Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G αB-crystallin mutant. Hum Mol Genet 12, 1609-1620.
63. Vicart P, Caron A, Guicheney P, Li Z, Prévost M-C, Faure A, Chateau D, Chapon F, Tome F, Dupret J-M, Paulin D & Fardeau M (1998) A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 20, 92-95.
64. Perng MD, Cairns L, van den IJssel P, Prescott A, Hutcheson AM & Quinlan RA (1999) Intermediate filament interactions can be altered by HSP27 and αB-crystallin. J Cell Sci 112, 2099-2112.
65. Fu L & Liang JJ-N (2003) Alteration of protein-protein interactions of congenital cataract crystallin mutants. Invest Ophthalmol Vis Sci 44, 1155-1159.
66. Fu L & Liang JJ-N (2002) Detection of protein-protein interactions among lens crystalline in a mammalian two-hybrid system assay. J Biol Chem 277, 4255-4260.
67. Xi JH, Bai F & Andley UP (2002) Reduced survival of lens epithelial cells in the αA-crystallin-knockout mouse. J Cell Sci 116, 1073-1085.
68. Andley UP, Song Z, Wawrousek EF & Bassnett S (1998) The molecular chaperone αA-crystallin enhances lens epithelial cell growth and resistance to UVA stress. J Biol Chem 273, 31252-31261.
69. Brady JP, Garland D, Duglas-Tabor Y, Robison WG Jr, Groome A & Wawrousek EF (1997) Targeted disruption of the mouse αA-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein αB-crystallin. Proc Natl Acad Sci USA 94, 884-889.
70. Liu J-P, Schlosser R, Ma W-Y, Dong Z, Feng H, Liu L, Huang X-Q, Liu Y & Li DW-C (2004) Human αA- and αB-crystallins prevent UVA-induced apoptosis through regulation of PKCa, RAF/MEK/ERK and AKT signaling pathways. Exp Eye Res 79, 393-403.
71. Wawrousek EF & Brady JP (1998) αB-crystallin gene knockout mice develop a severe fatal phenotype late in life. Invest Ophthalmol Vis Sci 39, S523.
72. Bai F, Xi JH, Wawrousek EF, Fleming TP & Andley UP (2003) Hyperproliferation and p53 status of lens epithelial cells derived from αB-crystallin knockout mice. J Biol Chem 278, 36876-36886.
73. Andley UP, Song Z, Wawrousek EF, Brady JP, Bassnett S & Fleming TP (2001) Lensepithelial cells derived from αB-crystallin knockout mice demonstrate hyper-proliferation and genomic instability. FASEB J 15, 221-229.
74. Kumarapeli ARK & Wang X (2004) Genetic modification of the heart: chaperones and the cytoskeleton. J Mol Cell Cardiol 37, 1097-1109.
75. Selcen D & Engel AG (2003) Myofibrillar myopathy caused by novel dominant negative αB-crystallin mutations. Ann Neurol 54, 804-810.
76. Wang X, Osinska H, Klevitsky R, Gerdes AM, Nieman M, Lorenz J, Hewett T & Robbins J (2001) Expression of R120G-αB-crystallin causes aberrant desmin and αB-crystallin aggregation and cardiomyopathy in mice. Circ Res 89, 84-91.
77. Wang X, Klevitsky R, Huang W, Glasford J, Li F & Robbins J (2003) αB-Crystallin modulates protein aggregation of abnormal desmin. Circ Res 93, 998-1005.
78. van den IJssel P, Wheelock R, Prescott A, Russell P & Quinlan RA (2003) Nuclear speckle localisation of the small heat shock protein αB-crystallin and its inhibition by the R 120G cardiomyopathy-linked mutation. Exp Cell Res 287, 249-261.
79. Sanbe A, Osinska H, Saffitz JE, Glabe CG, Kayed R, Maloyan A & Robbins J (2004) Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci USA 101, 10132-10136.
80. Ito H, Kamei K, Iwamoto I, Inaguma Y, Tsuzuki M, Kishikawa M, Shimada A, Hosokawa M & Kato K (2003) Hsp27 suppresses the formation of inclusion bodies induced by expression of R120GαB-crystallin, a cause of desmin-related myopathy. Cell Mol Life Sci 60, 1217-1223.
81. Hollander JM, Martin JL, Belke DD, Scott BT, Swanson E, Krishnamoorthy V & Dillmann WH (2004) Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 110, 3544-3552.
82. Vander Heide RS (2002) Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 282, H935-H941.
83. Ray PS, Martin JL, Swanson EA, Otani H, Dillmann WH & Das DK (2001) Transgene overexpression of αB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J 15, 393-402.
84. Martin JL, Mestril R, Hilal-Dandan R, Brunton LL & Dillmann WH (1997) Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 96, 4343-4348.
85. Morrison LE, Whittaker RJ, Klepper RE, Wawrousek EF & Glembotski CC (2004) Roles for αB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model. Am J Physiol Heart Circ Physiol 286, H847-H855.
86. Fan G-C, Chu G, Mitton B, Song Q, Yuan Q & Kranias EG (2004) Small heat-shock protein Hsp20 phosphorylation inhibits β-agonist-induced cardiac apoptosis. Circ Res 94, 1474-1482.
87. Morrison LE, Hoover HE, Thuerauf DJ & Glembotski CC (2003) Mimicking phosphorylation of αB-crystallin on serine-59 is necessary and sufficient to provide maximal protection of cardiac myocytes from apoptosis. Circ Res 92, 203-211.
88. Golenhofen N, Ness W, Koob R, Htun P, Schaper W & Drenckhahn D (1998) Ischemia-induced phosphorylation and translocation of stress protein αB-crystallin to Z lines of myocardium. Am J Physiol Heart Circ Physiol 274, H1457-H1464.
89. Yoshida K-i, Aki T, Harada K, Shama KMA, Kamoda Y, Suzuki A & Ohno S (1999) Translocation of HSP27 and MKBP in ischemic heart. Cell Struct Fund 24, 181-185.
90. Bluhm WF, Martin JL, Mestril R & Dillmann WH (1998) Specific heat shock proteins protect microtubules during simulated ischemia in cardiac myocytes. Am J Physiol Heart Circ Physiol 275, H2243-H2249.
91. Vandroux D, Schaeffer C, Tissier C, Lalande A, Bès S, Rochette L & Athias P (2004) Microtubule alteration is an early cellular reaction to the metabolic challenge in ischemic cardiomyocytes. Mol Cell Biochem 258, 99-108.
92. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895-899.
93. Dobson CM (2003) Protein folding and misfolding. Nature 426, 884-890.
94. Muchowski PJ & Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6, 11-22.
95. Wacker JL, Zareie MH, Fong H, Sarikaya M & Muchowski PJ (2004) Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partioning monomer. Nat Struct Mol Biol 11, 1215-1222.
96. Arrasate M, Mitra S, Schweitzer ES, Segal MR & Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810.
97. Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6, 1054-1061.
98. Forman MS, Trojanowski JQ & Lee VM-Y (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10, 1055-1063.
99. Landles C & Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. EMBO Report 5, 958-963.
100. Ross CA & Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10, S10-S17.
101. Tanaka M, Kim YM, Lee G, Junn E, Iwatsubo T & Mouradian MM (2004) Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective. J Biol Chem 279, 4625-4631.
102. Winklhofer KF, Henn IH, Kay-Jackson PC, Heller U & Tatzeit J (2003) Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones. J Biol Chem 278, 47199-47208.
103. Citron M (2004) Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci 5, 677-685.
104. Dabir DV, Trojanowski JQ, Richter-Landsberg C, Lee VM-Y & Forman MS (2004) Expression of the small heat-shock protein αB-crystallin in tauopathies with glial pathology. Am J Path 164, 155-166.
105. Yoo BC, Kim SH, Cairns N, Fountoulakis M & Lubec G (2001) Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 280, 249-258.
106. Renkawek K, Voorter CEM, Bosman GJCGM, van Workum FPA & de Jong WW (1994) Expression of αB-crystallin in Alzheimer's disease. Acta Neuropathol (Berl) 87, 155-160.
107. Shinohara H, Inaguma Y, Goto S, Inagaki T & Kato K (1993) αB crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J Neural Sci 119, 203-208.
108. Iwaki T, Wisniewski T, Iwaki A, Corbin E, Tomokane N, Tateishi J & Goldman JE (1992) Accumulation of αB-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Path 140, 345-356.
109. Lowe J, McDermott H, Pike I, Spendlove I, Landon M & Mayer RJ (1992) αB crystallin expression in nonlenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 166, 61-68.
110. Liang JJ-N (2000) Interaction between β-amyloid and lens αB-crystallin. FEBS Lett 484, 98-101.
111. Stege GJJ, Renkawek K, Overkamp PSG, Verschuure P, van Rijk AF, Reijnen-Aalbers A, Boelens WC, Bosman GJCGM & de Jong WW (1999) The molecular chaperone αB-crystallin enhances amyloid β neurotoxicity. Biochem Biophys Res Commun 262, 152-156.
112. Fonte V, Kapulkin V, Taft A, Fluet A, Friedman D & Link CD (2002) Interaction of intracellular β amyloid peptide with chaperone proteins. Proc Natl Acad Sci USA 99, 9439-9444.
113. 1-42 amyloidogenesis. FEBS Lett 416, 117-121.
114. Iwaki T, Iwaki A, Tateishi J, Sakaki Y & Goldman JE (1993) αB-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Path 143, 487-495.
115. Goldman JE & Corbin E (1991) Rosenthal fibers contain ubiquitinated αB-crystallin. Am J Path 139, 933-938.
116. Shinder GA, Lacourse M-C, Minotti S & Durham HD (2001) Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J Biol Chem 276, 12791-12796.
117. Strey CW, Spellman D, Stieber A, Gonatas JO, Wang X, Lambris JD & Gonatas NK (2004) Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am J Pathol 165, 1701-1718.
118. Okado-Matsumoto A & Fridovich I (2002) Amyotropic lateral sclerosis: a proposed mechanism. Proc Natl Acad Sci USA 99, 9010-9014.
119. Renkawek K, Stege GJJ & Bosman CJCGM (1999) Dementia, gliosis and expression of the small heat shock proteins Hsp27 and [alpha]B-crystallin in Parkinson's disease. Neuroreport 10, 2273-2276.
120. Schaffar G, Breuer P, Boteva R, Behrends C, Tzvetkov N, Strippel N, Sakahira H, Siegers K, Hayer-Hartl M & Hartl FU (2004) Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol Cell 15, 95-105.
121. Starckx S, Van den Steen PE, Verbeek R, van Noort JM & Opdenakker G (2003) A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys αB-crystallin and generates a promiscuous T cell epitope. J Neuroimmunol 141, 47-57.
122. van Noort JM, van Sechel AC, Bajramovic JJ, Ouagmirl ME, Polman CH, Lassmann H & Ravid R (1995) The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375, 798-801.
123. Chabas D, Baranzini SE, Mitchell D, Bernard CCA, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR & Steinman L (2001) The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731-1735.
124. van Veen T, van Winsen L, Crusius JBA, Kalkers NF, Barkhof F, Pena AS, Polman CH & Uitdehaag BMJ (2003) αB-Crystallin genotype has impact on the multiple sclerosis phenotype. Neurology 61, 1245-1249.
125. Vojdani A, Vojdani E & Cooper E (2003) Antibodies to myelin basic protein, myelin oligodendrocytes peptides, α-B-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. J Int Med 254, 363-374.
126. Tang B-S, Zhao G-H, Luo W, Xia K, Cai F, Pan Q, Zhang R-X, Zhang F-F, Liu X-M, Chen B, Zhang C, Shen L, Jiang H, Long Z-G, Dai H- & P (2005) Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 116, 222-224.
127. Irobi J, Van Impe K, Seeman P, Jordanova A, Dierick I, Verpoorten N, Michalik A, De Vriendt E, Jacobs A, Van Gerwen V, Vennekens K, Mazanec R, Tournev I, Hilton-Jones D, Talbot K, Kremensky I, Van Den Bosch L, Robberecht W, Vandekerckhove J, Van Broeckhoven C, Gettemans J, De Jonghe P & Timmerman V (2004) Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 36, 597-601.
128. Evgrafov OV, Mersiyanova I, Irobi J, Van Den Bosch L, Dierick I, Leung CL, Schagina O, Verpoorten N, Van Impe K, Fedotov V, Dadali E, Auer-Grumbach M, Windpassinger C, Wagner K, Mitrovic Z, Hilton-Jones D, Talbot K, Martin J-J, Vasserman N, Tverskaya S, Polyakov A, Liem RKH, Gettemans J, Robberecht W, De Jonghe P & Timmerman V (2004) Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 36, 602-606.
129. Chelouche-Lev D, Kluger HM, Berger AJ, Rimm DL & Price JE (2004) αB-crystallin as a marker of lymph node involvement in breast carcinoma. Cancer 100, 2543-2548.
130. Ungar DR, Hailat N, Strahler JR, Kuick RD, Brodeur GM, Seeger RC, Reynolds CP & Hanash SM (1994) Hsp27 expression in neuroblastoma: correlation with disease stage. J Nat Can Inst 86, 780-784.
131. Tetu B, Lacasse B, Bouchard HL, Lagace R, Huot J & Landry J (1992) Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study. Can Res 52, 2325-2328.
132. Ciocca DR, Rozados VR, Carrion FDC, Gervasoni SI, Matar P & Scharovsky OG (2003) Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin. Cell Stress Chaperones 8, 26-36.
133. Yonekura N, Yokota S, Yonekura K, Dehari H, Arata S, Kohama G & Fujii N (2003) Interferon-γ downregulates Hsp27 expression and suppresses the negative regulation of cell death in oral squamous cell carcinoma lines. Cell Death Different 10, 313-322.
134. Elpek GO, Karaveli Ş, Şimşek T, Kele, N & Aksoy NH (2003) Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS 111, 523-530.
135. Hansen RK, Parra I, Hilsenbeck SG, Himelstein B & Fuqua SAW (2001) Hsp27-induced MMP-9 expression in influenced by the Src tyrosine protein kinase Yes. Biochem Biophys Res Commun 282, 186-193.
136. Bonkhoff H, Fixemer T, Hunsicker I & Remberger K (2000) Estrogen receptor gene expression and its relation to the estrogen-inducible HSP27 heat shock protein in hormone refractory prostate cancer. Prostate 45, 36-41.
137. Geisler JP, Geisler HE, Tammela J, Miller GA, Wiemann MC & Zhou Z (1999) A study of heat shock protein 27 in endometrial carcinoma. Gynecol Oncol 72, 347-350.
138. Aoyama A, Steiger RH, Fröhli E, Schäfer R, von Deimling A, Wiestler OD & Klemenz R (1993) Expression of αB-crystallin in human brain tumors. Int J Cancer 55, 760-764.
139. Thor A, Benz C, Moore D, 2nd Goldman E, Edgerton S, Landry J, Schwanz L, Mayall B, Hickey E & Weber LA (1991) Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Can Inst 83, 170-178.
140. de Wit NJW, Verschuure P, Kappé G, King SM, de Jong WW, van Muijen GNP & Boelens WC (2004) Testis-specific human small heat shock protein HSPB9 is a cancer/testis antigen, and potentially interacts with the dynein subunit TCTEL1. Eur J Cell Biol 83, 337-345.
141. Aldrian S, Trautinger F, Fröhlich I, Berger W, Micksche M & Kindas-Mügge I (2002) Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro. Cell Stress Chaperones 7, 177-185.
142. Aldrian S, Kindas-Mügge I, Trautinger F, Fröhlich I, Gsur A, Herbacek I, Berger W & Micksche M (2003) Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system. Cell Stress Chaperones 8, 249-257.
143. r 27,000 heat shock protein (hsp27). Cell Growth Different 7, 1167-1174.
144. Favet N, Duverger O, Loones M-T, Poliard A, Kellermann O & Morange M (2001) Overexpression of murine small heat shock protein HSP25 interferes with chondrocyte differentiation and decreases cell adhesion. Cell Death Different 8, 603-613.
145. Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK & Fuqua SA (1993) The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Can Res 53, 4443-4448.
146. r 27,000 heat shock protein. Can Res 51, 5245-5252.
147. Jantschitsch C, Trautinger F, Klosner G, Gsur A, Herbacek I, Micksche M & Kindås-Mügge I (2002) Overexpression of Hsp25 in K1735 murine melanoma cells enhances susceptibility to natural killer cytotoxicity. Cell Stress Chaperones 7, 107-117.
148. Treweek TM, Morris AM & Carver JA (2003) Intracellular protein unfolding and aggregation: the role of small heat-shock chaperone proteins. Aust J Chem 56, 357-367.
149. Hopkins DA, Plumier J-CL & Currie RW (1998) Induction of the 27-kDa heat shock protein (Hsp27) in the rat medulla oblongata after vagus nerve injury. Exp Neurol 153, 173-183.
150. Hsu A-L, Murphy CT & Kenyon C (2003) Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300, 1142-1145.
151. Clark JI & Huang Q-L (1996) Modulation of the chaperone-like activity of bovine α-crystallin. Proc Natl Acad Sci USA 93, 15185-15189.
152. Huot J, Houle F, Rousseau S, Deschesnes RG, Shah GM & Landry J (1998) SAPK2/p38-dependent F-actin reorganization regulates early membrane Webbing during stress-induced apoptosis. J Cell Biol 143, 1361-1373.
153. Kamal A, Boehm MF & Burrows FJ (2004) Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med 10, 283-290.
154. Beliakoff J & Whitesell L (2004) Hsp90: an emerging target for breast cancer therapy. Anti-Cancer Drugs 15, 651-662.
155. Kieran D, Kalmar B, Dick JRT, Riddoch-Contreras J, Burnstock G & Greensmith L (2004) Treatment with arimoclomol, a coinducor of heat shock proteins, delays disease progression in ALS mice. Nat Med 10, 402-405.
156. Griffin TM, Valdez TV & Mestril R (2004) Radicicol activates heat shock protein expression and cardioprotection in neonatal rat cardiomyocytes. Am J Physiol Heart Circ Physiol 287, H1081-H1088.
157. Ding Z, Fach C, Sasse A, Gödecke A & Schrader J (2004) A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Ther 11, 260-265.
158. Agrawal RS, Muangman S, Layne MD, Melo L, Perrella MA, Lee RT, Zhang L, Lopez- Ilasaca M & Dzau VJ (2004) Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival. Gene Ther 11, 962-969.
159. Ehrnsperger M, Hergersberg C, Wienhues U, Nichtl A & Buchner J (1998) Stabilization of proteins and peptides in diagnostic immunological assays by the molecular chaperone Hsp25. Anal Biochem 259, 218-225.
160. Srivastava P (2004) Heat shock proteins and immune response: methods to madness. Methods 32, 1-2.
161. Gough MJ, Melcher AA, Crittenden MR, Sanchez-Perez L, Voellmy R & Vile RG (2004) Induction of cell stress through gene transfer of an engineered heat shock transcription factor enhances tumor immunogenicity. Gene Ther 11, 1099-1104.
162. Kawanishi K, Shiozaki H, Doki Y, Sakita I, Inoue M, Yano M, Tsujinaka T, Shamma A & Monden M (1999) Prognostic significance of heat shock protein 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 85, 1649-1657.
163. Brenner BG & Wainberg MA (1999) Heat shock protein-based therapeutic
164. Suto R & Srivastava PK (1995) A mechanism for the specific immunogenenicity of heat shock protein-chaperoned peptides. Science 269, 1585-1588.